rs2236142

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000416671.5(CHEK2):​n.-194C>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.638 in 846,056 control chromosomes in the GnomAD database, including 176,623 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 33322 hom., cov: 32)
Exomes 𝑓: 0.63 ( 143301 hom. )

Consequence

CHEK2
ENST00000416671.5 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.264

Publications

25 publications found
Variant links:
Genes affected
CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
HSCB (HGNC:28913): (HscB mitochondrial iron-sulfur cluster cochaperone) This gene encodes a DnaJ-type co-chaperone and member of the heat shock cognate B (HscB) family of proteins. The encoded protein plays a role in the synthesis of iron-sulfur clusters, protein cofactors that are involved in the redox reactions of mitochondrial electron transport and other processes. Cells in which this gene is knocked down exhibit reduced activity of iron-sulfur cluster-dependent enzymes including succinate dehydrogenase and aconitase. The encoded protein may stimulate the ATPase activity of the mitochondrial stress-70 protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
HSCB Gene-Disease associations (from GenCC):
  • anemia, sideroblastic, 5
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 22-28741956-G-C is Benign according to our data. Variant chr22-28741956-G-C is described in ClinVar as Benign. ClinVar VariationId is 1268378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.704 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHEK2NM_007194.4 linkc.-194C>G upstream_gene_variant ENST00000404276.6 NP_009125.1 O96017-1
HSCBNM_172002.5 linkc.-140G>C upstream_gene_variant ENST00000216027.8 NP_741999.3 Q8IWL3A0A384NYJ4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHEK2ENST00000404276.6 linkc.-194C>G upstream_gene_variant 1 NM_007194.4 ENSP00000385747.1 O96017-1
HSCBENST00000216027.8 linkc.-140G>C upstream_gene_variant 1 NM_172002.5 ENSP00000216027.3 Q8IWL3

Frequencies

GnomAD3 genomes
AF:
0.656
AC:
99757
AN:
151974
Hom.:
33304
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.711
Gnomad AMI
AF:
0.693
Gnomad AMR
AF:
0.607
Gnomad ASJ
AF:
0.496
Gnomad EAS
AF:
0.374
Gnomad SAS
AF:
0.424
Gnomad FIN
AF:
0.688
Gnomad MID
AF:
0.532
Gnomad NFE
AF:
0.677
Gnomad OTH
AF:
0.588
GnomAD4 exome
AF:
0.633
AC:
439625
AN:
693964
Hom.:
143301
Cov.:
9
AF XY:
0.625
AC XY:
222022
AN XY:
355154
show subpopulations
African (AFR)
AF:
0.715
AC:
12354
AN:
17270
American (AMR)
AF:
0.564
AC:
12728
AN:
22574
Ashkenazi Jewish (ASJ)
AF:
0.487
AC:
7737
AN:
15874
East Asian (EAS)
AF:
0.355
AC:
11459
AN:
32278
South Asian (SAS)
AF:
0.437
AC:
23192
AN:
53068
European-Finnish (FIN)
AF:
0.685
AC:
20563
AN:
30026
Middle Eastern (MID)
AF:
0.478
AC:
1881
AN:
3934
European-Non Finnish (NFE)
AF:
0.678
AC:
328803
AN:
484876
Other (OTH)
AF:
0.614
AC:
20908
AN:
34064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8285
16570
24854
33139
41424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5672
11344
17016
22688
28360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.656
AC:
99819
AN:
152092
Hom.:
33322
Cov.:
32
AF XY:
0.651
AC XY:
48419
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.711
AC:
29505
AN:
41488
American (AMR)
AF:
0.607
AC:
9275
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.496
AC:
1721
AN:
3472
East Asian (EAS)
AF:
0.374
AC:
1924
AN:
5150
South Asian (SAS)
AF:
0.423
AC:
2041
AN:
4820
European-Finnish (FIN)
AF:
0.688
AC:
7274
AN:
10580
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.677
AC:
46056
AN:
67992
Other (OTH)
AF:
0.585
AC:
1237
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1777
3554
5332
7109
8886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
786
1572
2358
3144
3930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.680
Hom.:
4425
Bravo
AF:
0.650
Asia WGS
AF:
0.385
AC:
1339
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
7.5
DANN
Benign
0.75
PhyloP100
-0.26
PromoterAI
-0.0071
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2236142; hg19: chr22-29137944; COSMIC: COSV53263634; API